Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

BDH Industries Ltd (BDH) Share Price & Fundamentals

Company Overview

Founded Year

1990

Listed Year

1995

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Ms. Jayashree Nair, Chairperson & Managing Director; Mr. S.C. Kachhara, Joint Managing Director & CFO.

Website

https://www.bdhind.com

Company Facts

What we do

BDH Industries Ltd manufactures pharmaceuticals, focusing on antibiotics and novel drug delivery systems, and operates renewable energy wind turbines.

Founded in

1,990

Market share

Established player with diversified offerings in pharmaceuticals and emerging renewable energy segment.

Problem solved

Provides effective therapeutic formulations and renewable energy solutions addressing health and sustainable power needs.

Top clients or who we serve

Serves healthcare providers, pharma distributors, and energy markets across India and exports internationally (B2B, B2C).

Key management

Ms. Jayashree Nair, Chairperson & Managing Director; Mr. S.C. Kachhara, Joint Managing Director & CFO.

Our journey and innovations

Started by acquiring Bombay Drug House Pvt Ltd, expanded pharmaceuticals with R&D focus on novel drug delivery, entered renewables with wind power in 2024.

Where we operate

Domestic Indian market and international exports; renewable energy projects in Rajasthan, India.

Top products or what we offer

Pharmaceutical drug formulations in antibiotics and anti-inflammatory categories; wind energy generation units.

Top brands

-

Raw materials needed

Active pharmaceutical ingredients (APIs), excipients for drug manufacturing; turbine components for renewable energy.

Raw materials supplier

-

Recurring vs cyclical contribution

Pharmaceuticals revenue is recurring; renewable energy is new but adds steady revenue.

Our industry position

Mid-sized pharmaceutical manufacturer with growing footprint; new entrant in renewable energy sector.

Financial highlights

FY25 revenue Rs. 66.5 crore; net profit Rs. 9.27 crore; slight revenue decline but solid profitability.

Geographical revenue split

Approximately 52% revenue from India, 48% from overseas markets.

Order book

-

Whats driving growth

Product line expansion, investment in novel drug delivery R&D, entry into renewable energy, and export markets.

Our future plans

Expand renewable energy capacity; strengthen pharmaceuticals R&D and production capabilities.

Our green promise

Operational wind turbines generating clean electricity; commitment to sustainable practices in manufacturing.

Our people and values

112 employees; focus on inclusive culture, safety, and employee well-being.

Key challenges ahead

Navigating market competition in pharma, scaling renewable energy operations, and managing export fluctuations.

Interesting facts

Operates India’s wind energy project while maintaining a patented R&D center for novel pharma formulations.

Risks and strategy

Market volatility managed by diversifying product segments and geographic presence; risk mitigation via strong compliance and R&D.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers, pharma distributors, and energy markets across India and exports internationally (B2B, B2C).

Top Products

Top Products

Pharmaceutical drug formulations in antibiotics and anti-inflammatory categories; wind energy generation units.

Price Movement & Share Holding

Today's High/Low

390.1433.9

52 Week High/Low

340.15610
Past Returns

1 week

-9.82%

1 month

-18.16%

3 month

-28.62%

1 year

-4.19%

3 year

139.86%

5 year

227.12%

Share Holding

Promoters

49.7%

FII

0.28%

DII

0%

Retail

36.36%

Others

13.67%

Company Overview

Founded Year

1990

Listed Year

1995

Headquarter

Mumbai, Maharashtra, India

MD/CEO

Ms. Jayashree Nair

Website

https://www.bdhind.com

Price Movement & Share Holding

Today's High/Low

390.1433.9

52 Week High/Low

340.15610

Past Returns

1 week

-9.82%

1 month

-18.16%

3 month

-28.62%

1 year

-4.19%

3 year

139.86%

5 year

227.12%

Share Holding

Promoters

49.7%

FII

0.28%

DII

0%

Retail

36.36%

Others

13.67%

Company Facts

What we do

BDH Industries Ltd manufactures pharmaceuticals, focusing on antibiotics and novel drug delivery systems, and operates renewable energy wind turbines.

Founded in

1990

Market share

Established player with diversified offerings in pharmaceuticals and emerging renewable energy segment.

Problem solved

Provides effective therapeutic formulations and renewable energy solutions addressing health and sustainable power needs.

Top clients or who we serve

Serves healthcare providers, pharma distributors, and energy markets across India and exports internationally (B2B, B2C).

Key management

Ms. Jayashree Nair, Chairperson & Managing Director; Mr. S.C. Kachhara, Joint Managing Director & CFO.

Our journey and innovations

Started by acquiring Bombay Drug House Pvt Ltd, expanded pharmaceuticals with R&D focus on novel drug delivery, entered renewables with wind power in 2024.

Where we operate

Domestic Indian market and international exports; renewable energy projects in Rajasthan, India.

Top products or what we offer

Pharmaceutical drug formulations in antibiotics and anti-inflammatory categories; wind energy generation units.

Raw materials needed

Active pharmaceutical ingredients (APIs), excipients for drug manufacturing; turbine components for renewable energy.

Recurring vs cyclical contribution

Pharmaceuticals revenue is recurring; renewable energy is new but adds steady revenue.

Our industry position

Mid-sized pharmaceutical manufacturer with growing footprint; new entrant in renewable energy sector.

Financial highlights

FY25 revenue Rs. 66.5 crore; net profit Rs. 9.27 crore; slight revenue decline but solid profitability.

Geographical revenue split

Approximately 52% revenue from India, 48% from overseas markets.

Whats driving growth

Product line expansion, investment in novel drug delivery R&D, entry into renewable energy, and export markets.

Our future plans

Expand renewable energy capacity; strengthen pharmaceuticals R&D and production capabilities.

Our green promise

Operational wind turbines generating clean electricity; commitment to sustainable practices in manufacturing.

Our people and values

112 employees; focus on inclusive culture, safety, and employee well-being.

Key challenges ahead

Navigating market competition in pharma, scaling renewable energy operations, and managing export fluctuations.

Interesting facts

Operates India’s wind energy project while maintaining a patented R&D center for novel pharma formulations.

Risks and strategy

Market volatility managed by diversifying product segments and geographic presence; risk mitigation via strong compliance and R&D.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers, pharma distributors, and energy markets across India and exports internationally (B2B, B2C).

Top Products

Top Products

Pharmaceutical drug formulations in antibiotics and anti-inflammatory categories; wind energy generation units.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions